Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration
- 4 September 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 172 (1) , 27-36
- https://doi.org/10.1016/s0304-3835(01)00617-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- Reovirus Therapy of Tumors with Activated Ras PathwayScience, 1998
- Complete Regression of Human Neuroblastoma Xenografts in Athymic Mice After Local Newcastle Disease Virus TherapyJNCI Journal of the National Cancer Institute, 1994
- Viruses as Oncolytic Agents: a New Age for "Therapeutic" Viruses?JNCI Journal of the National Cancer Institute, 1994
- Newcastle disease virus selectively kills human tumor cellsJournal of Surgical Research, 1992
- Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axisEuropean Journal of Immunology, 1989
- Newcastle Disease Virus as an Antineoplastic Agent: Induction of Tumor Necrosis Factor- and Augmentation of Its Cytotoxicity2JNCI Journal of the National Cancer Institute, 1988
- Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passageCancer Genetics and Cytogenetics, 1987
- Newcastle Disease Virus: Virus Particle and RNA Synthesis in Different Host Cells and at Different TemperaturesJournal of General Virology, 1974
- Newcastle disease virus as an antineoplastic agentCancer, 1965